A Digital Care Solution for Coronary Artery Disease Patients
Coronary Artery Disease
About this trial
This is an interventional treatment trial for Coronary Artery Disease focused on measuring coronary artery disease, digital application, lifestyle change, remote monitoring, clinical outcome, quality of life
Eligibility Criteria
Inclusion Criteria: Adults diagnosed with coronary artery disease Fluent in verbal and written Icelandic Capacity to give informed consent Capacity to operate a smartphone Exclusion Criteria: Not owning a smartphone compatible with the Sidekick Health app or not willing to have it installed on their device Not able or willing to comply with study intervention/scheduled measures and visits Having another serious medical condition (e.g., cancer, endocarditis, heart failure (EF<40%), history of cardiac arrest) Active alcohol or drug abusers
Sites / Locations
- Landspítali University HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Digital Care Solution group
Standard of Care - control group
Participants will be instructed to download the SKH mobile app to which the participants will have access for 12 months, and the participants will receive an access code to activate the SKH CAD program. The aim of the program is to empower self-assessment of CAD symptoms as well as positive lifestyle change by gamification, altruistic rewards, and engaging content with relevant tasks or missions to be completed. Beyond this, all patients in the interventional arm will also receive standard of care as defined below for the control arm.
The participants in the Standard of Care - control group will receive an information leaflet about relevant lifestyle modifications for CAD. After baseline measurements and data collection, follow-up and continuous care will be as usual in outpatient care (i.e., Standard of Care).